The Pharmacy Times® Oncology Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to oncology pharmacists.
July 1st 2025
Obecabtagene autoleucel shows promising efficacy and safety in treating relapsed/refractory B-ALL, benefiting patients of all ages, including older adults.
COPD Linked to Higher Lung Cancer Risk Among Smokers
December 21st 2015Although smoking is a well-known risk factor for lung cancer, the results of a recent study indicate that smokers with chronic obstructive pulmonary disease (COPD) face a significantly higher risk of developing lung cancer than smokers without the respiratory condition.
Read More